AXERT Early miGraine Intervention Study (AEGIS): efficacy and safety of almotriptan malate (AXERT) versus placebo for the acute treatment of migraine headache
Latest Information Update: 11 May 2009
At a glance
- Drugs Almotriptan (Primary)
- Indications Migraine
- Focus Therapeutic Use
- Acronyms AEGIS
- 23 Aug 2007 The expected completion date for this trial is now 1 Jun 2005.
- 05 Nov 2005 New trial record.